| Cas No.: | 171500-79-1 |
| 名称: | |
| 别名: | Dalbavancin;MDL 63397;A-A-1, Dalbavancin Ao, BI 397, MDL 63397;Dalbavancin(BI 397, MDL 63397) |
| SMILES: | CC(C)CCCCCCCCC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=C3C=C4C=C2OC5=C(C=C(C=C5)[C@H]([C@H]6C(=O)NC(C7=CC(=CC(=C7C8=C(C=CC(=C8)[C@H](C(=O)N6)NC(=O)[C@@H]4NC(=O)[C@@H]9C1=CC(=CC(=C1Cl)O)OC1=C(C=CC(=C1)[C@H](C(=O)N[C@H](CC1=CC=C(O3)C=C1)C(=O)N9)N |
| 分子式: | C88H100Cl2N10O28 |
| 分子量: | 1816.69 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. For the detailed information of Dalbavancin, the solubility of Dalbavancin in water, the solubility of Dalbavancin in DMSO, the solubility of Dalbavancin in PBS buffer, the animal experiment（test） (test) of Dalbavancin, the cell expriment (test) of Dalbavancin, the in vivo, in vitro and clinical trial test of Dalbavancin, the EC50, IC50,and Affinity of Dalbavancin,, please contact DC Chemicals. |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |
MSDS
COA
| LOT NO. | DOWNLOAD |
|
|
|
| 2018-0101 |
|
